Lurie Cancer Center Member
Alexander H Stegh, PhD
Assistant Professor, Medicine; Feinberg School of Medicine
View Publications Listing
Our research program is aimed at understanding the genetic program that underlies the pathogenesis of Glioblastoma multiforme (GBM), the most prevalent and malignant form of brain cancer. Applying a combination of cell/molecular biology, oncogenomic and mouse engineering approaches, we are dedicated to systematically characterize novel gliomagenic oncogenes and tumor suppressors. We will functionally delineate and validate these pathways towards pharmaceutical opportunities using sophisticated cell culture and animal models.
- Cancer Genes Turned Off in Brain Cancer
- Protein Shown to Reduce Body’s Ability to Kill Brain Tumors
- Brain Cancer Gene Silenced by Nanotechnology-Based Drug